The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers

International Journal of Pharmaceutics

Volumn 416, Issue 1, 2011, Pages 129-135

  Young, Paul M ^a   Wood, Owen ^a   Ooi, Jesslynn ^a   Traini, Daniela ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Active sites; Dry powder inhaler; Inhalation medicine; Powder blending; Spherical carrier

Indexed keywords

DRUG CARRIER; POLYSTYRENE; SALBUTAMOL SULFATE;

AEROSOL; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STRUCTURE; LOADING DRUG DOSE; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL;

AEROSOLS; ALBUTEROL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRY POWDER INHALERS; PARTICLE SIZE; POLYSTYRENES; POWDERS; SURFACE PROPERTIES;

EID: 80051784971     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.06.020     Document Type: Article

References (20)

1. H. Adi, I. Larson, H. Chiou, P. Young, D. Traini, and P. Stewart Role of agglomeration in the dispersion of salmeterol xinafoate from mixtures for inhalation with differing drug to fine lactose ratios J. Pharm. Sci. 97 2008 3140 3152
2. A.H. de Boer, B.H.J. Dickhoff, P. Hagedoorn, D. Gjaltema, J. Goede, D. Lambregts, and H.W. Frijlink A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation Int. J. Pharm. 294 2005 173 184 (Pubitemid 40462333)
3. B.H.J. Dickhoff, A.H. de Boer, D. Lambregts, and H.W. Frijlink The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time Eur. J. Pharm. Biopharm. 56 2003 291 302 (Pubitemid 37072114)
4. B.H.J. Dickhoff, A.H. de Boer, D. Lambregts, and H.W. Frijlink The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation Eur. J. Pharm. Biopharm. 59 2005 197 205 (Pubitemid 39573453)
5. M.J. Donovan, and H.D. Smyth Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations Int. J. Pharm. 402 2010 1 9
6. D. El-Sabawi, S. Edge, R. Price, and P. Young Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: surface smoothing effects Drug Dev. Ind. Pharm. 32 2006 1135 1138 (Pubitemid 44721727)
7. E. Guenette, A. Barrett, D. Kraus, R. Brody, L. Harding, and G. Magee Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design Int. J. Pharm. 380 2009 80 88
8. J.A. Hersey Ordered mixing - new concept in powder mixing practice Powder Technol. 11 1975 41 44
9. N. Islam, P. Stewart, I. Larson, and P. Hartley Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures J. Pharm. Sci. 93 2004 1030 1038 (Pubitemid 38420412)
10. N. Islam, P. Stewart, I. Larson, and P. Hartley Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm. Res. 21 2004 492 499 (Pubitemid 38338985)
11. M.D. Jones, and R. Price The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations Pharm. Res. 23 2006 1665 1674 (Pubitemid 44200528)
12. Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate Int. J. Pharm. 172 1998 179 188 (Pubitemid 28430255)
13. M.D. Louey, and P.J. Stewart Particle interactions involved in aerosol dispersion of ternary interactive mixtures Pharm. Res. 19 2002 1524 1531 (Pubitemid 35266558)
14. J. Ooi, D. Traini, S. Hoe, W. Wong, and P.M. Young Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems Int. J. Pharm 413 2011 1 9
15. I.J. Smith, and M. Parry-Billings The inhalers of the future? a review of dry powder devices on the market today Pulm. Pharmacol. Therap. 16 2003 79 95 (Pubitemid 36372063)
16. D. Traini, P.M. Young, F. Thielmann, and M. Acharya The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations Drug Dev. Ind. Pharm. 34 2008 992 1001
17. P.A. Young, S. Edge, D. Traini, M.D. Jones, R. Price, D. El-Sabawi, C. Urry, and C. Smith The influence of dose on the performance of dry powder inhalation systems Int. J. Pharm. 296 2005 26 33 (Pubitemid 40693369)
18. P.M. Young, S. Edge, D. Traini, M.D. Jones, R. Price, D. El-Sabawi, C. Urry, and C. Smith The influence of dose on the performance of dry powder inhalation systems Int. J. Pharm. 296 2005 26 33 (Pubitemid 40693369)
19. P.M. Young, P. Kwok, H. Adi, H.K. Chan, and D. Traini Lactose composite carriers for respiratory delivery Pharm. Res. 26 2009 802 810
20. P.M. Young, D. Traini, H.K. Chan, H. Chiou, S. Edge, and T. Tee The influence of mechanical processing dry powder inhaler carriers on drug aerosolisation performance J. Pharm. Sci 96 5 2007 1331 1341 (Pubitemid 46804584)